Akihiko Okuyama

TL;DR: Long‐term outcome in recipients of ABO‐incompatible living kidneys is excellent, and graft survival rates were significantly higher in patients 29 years or younger than in patients 30 years or older and in patients who received anticoagulation therapy than in those who did not receive such therapy.

TL;DR: Results indicate that FTY720 is a potent anticancer agent that induces cancer cell apoptosis and is markedly effective for prevention of metastasis.

TL;DR: Findings indicate that a novel type 3 5α‐steroid reductase, SRD5A3, is associated with DHT production and maintenance of androgen–androgen receptor‐pathway activation in HRPC cells, and that this enzymatic activity should be a promising molecular target for prostate cancer therapy.

TL;DR: HCV infection has a significant impact on kidney transplant recipients over the long term and in particular affects them in the second decade, and a pilot study revealed only partial efficacy of IFN-alpha therapy for HCV-infected recipients, but with the high risk of acute rejection.

TL;DR: This is the first report about CYP1B1 regulation in human clinical prostate samples showing that hypomethylation of the CYP 1B1 gene may play an important role in prostate cancer.